Roche Pegasys Hep C Monotherapy Launch Expected Before Combo Approval

Roche Pegasys hepatitis C monotherapy could launch as early as October, two months before the expected approval of the combination pegylated interferon alfa-2a/ribavirin product

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet